QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 3, 页码: 327-335 作者:  Li, Hui-hui;  Li, Jun;  Zhang, Xian-jing;  Li, Jiao-meng;  Xi, Cong 收藏  |  浏览/下载：25/0  |  提交时间：2020/07/01 23,24-dihydrocucurbitacin B  lipid-lowering agent  LDLR  PCSK9  HNF1 alpha  SREBP2   2324dihydrocucurbitacinbpromoteslipidclearancebydualtranscriptionalregulationofldlrandpcsk9 期刊论文 actapharmacologicasinica, 2020, 卷号: 41, 期号: 3, 页码: 327 作者:  Li Huihui;  Li Jun;  Zhang Xianjing;  Li Jiaomeng;  Xi Cong 收藏  |  浏览/下载：44/0  |  提交时间：2020/07/01 23  24-dihydrocucurbitacin B  lipid-lowering agent  LDLR  PCSK9  HNF1α  SREBP2   Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia 期刊论文 ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 6, 页码: 1216-1230 作者:  Wu, Chenglin;  Xi, Cong;  Tong, Junhua;  Zhao, Jing;  Jiang, Hualiang 收藏  |  浏览/下载：49/0  |  提交时间：2020/07/01 PCSK9  Tetrahydroprotoberberine derivatives  Low-density lipoprotein cholesterol  Lipid-lowering  PCSK9 expression  Low-density lipoprotein receptor  Total cholesterol  Hyperlipidemia hamster   designsynthesisandbiologicalevaluationofnoveltetrahydroprotoberberinederivativesthpbsasproproteinconvertasesubtilisinkexintype9pcsk9modulatorsforthetreatmentofhyperlipidemia 期刊论文 actapharmaceuticasinicab, 2019, 卷号: 9, 期号: 6, 页码: 1216 作者:  Wu Chenglin;  Xi Cong;  Tong Junhua;  Zhao Jing;  Jiang Hualiang 收藏  |  浏览/下载：52/0  |  提交时间：2020/07/01 DOPAMINE D-1  BERBERINE  EXPRESSION  INHIBITORS  IDENTIFICATION  CHOLESTEROL  MUTATIONS  LDLR  PCSK9  Tetrahydroprotoberberine derivatives  Low-density lipoprotein cholesterol  Lipid-lowering  PCSK9 expression  Low-density lipoprotein receptor  Total cholesterol  Hyperlipidemia hamster   Proteomics analysis reveals a potential new target protein for the lipid-lowering effect of Berberine8998 期刊论文 ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 9, 页码: 1473-1482 作者:  Yu, Cheng-yin;  Liu, Gang-yi;  Liu, Xiao-hui;  Gui, Yu-zhou;  Liu, Hai-ming 收藏  |  浏览/下载：43/0  |  提交时间：2019/01/08 berberine  berberine8998  proteomics  lipid-lowering  cholesterol  triglycerides  LDL-C  fatty acid metabolism  hypercholesterolemia  obesity   Jatrophane diterpenoids from Euphorbia helioscopia and their lipid-lowering activities 期刊论文 FITOTERAPIA, 2018, 卷号: 128, 页码: 102-111 作者:  Li, Jun;  Li, Hui-hui;  Wang, Wen-qiong;  Song, Wei-bin;  Wang, Yi-ping 收藏  |  浏览/下载：27/0  |  提交时间：2019/01/08 Euphorbia helioscopia  Jatrophanes  Hyperlipidemia  Lipid-lowering  LDL receptor   proteomicsanalysisrevealsapotentialnewtargetproteinforthelipidloweringeffectofberberine8998 期刊论文 actapharmacologicasinica, 2018, 卷号: 39, 期号: 9, 页码: 1473 作者:  u Chengyin;  Liu Gangyi;  Liu Xiaohui;  Gui Yuzhou;  Liu Haiming 收藏  |  浏览/下载：2/0  |  提交时间：2020/07/01 DISEASE  ATHEROSCLEROSIS  IDENTIFICATION  CHALLENGES  EFFICACY  RECEPTOR  berberine  berberine8998  proteomics  lipid-lowering  cholesterol  triglycerides  LDL-C  fatty acid metabolism  hypercholesterolemia  obesity   Alkaloids from lotus leaf and related bioactivities 期刊论文 Chinese Traditional Patent Medicine, 2014, 卷号: 36, 期号: 11, 页码: 2330-2333 作者:  Yuan Pulong;  Chen Liang;  Liu Xiaoyu;  Yu Bangwei;  Haung Qi 收藏  |  浏览/下载：10/0  |  提交时间：2019/01/08 lotus leaf(Nelumbo nucifera)  alkaloids  2-hydroxy-l-methoxyaporphine  antibacterial  lipid-lowering  hypoglycemic   Current status of studies on Acyl-CoA: Cholesterol Acyltransferase (ACAT) inhibitors 期刊论文 Chinese Journal New Drugs, 2005, 卷号: 14, 期号: 4, 页码: 396-400 作者:  Din Derong;  Shen Jingkang 收藏  |  浏览/下载：7/0  |  提交时间：2019/01/08 ACAT inhibitor  atherosclerosis  cholesterol-lowering  lipid-lowering